濮阳东方男科在什么地方濮阳东方医院男科看早泄,濮阳东方医院男科收费高不,濮阳东方男科医院割包皮便宜吗,濮阳东方医院看男科病非常的专业,濮阳东方医院治疗阳痿技术可靠,濮阳东方医院男科割包皮评价非常高,濮阳东方医院男科割包皮手术多少钱

YUEYANG, Hunan, June 2 (Xinhua) -- The population of finless porpoises, an endangered species of freshwater dolphin that lives in China's Yangtze River, may decrease by over 80 percent over the next 30 years, experts said on Thursday after conducting a field survey along the river.The rare species will edge closer to extinction if no action is taken, said Wang Ding, a dolphin expert from the Hydrobiology Institute of the Chinese Academy of Sciences.Wang's team conducted a survey on Poyang Lake, Dongting Lake and other locations along the Yangtze from Sunday to Wednesday this week.The dolphin population currently stands at 1,000, even lower than that of the giant panda, Wang said.The dolphin population is decreasing by a rate of 6.4 percent annually, Wang said."The next ten years will be a critical period for the conservation of this species," Wang said.A long-lasting drought in central China has lowered water levels in many of the region's lakes and rivers, doing great harm to the dolphins' habitat and leading to a decrease in population, Wang said.Mei Zhigang, a member of Wang's survey team, said that human activity has also contributed to the dropping population.Mei said that large numbers of shipping vessels on the Yangtze have impeded the dolphins' migration path, causing them to reproduce less frequently.

BEIJING, Sept. 6 (Xinhuanet) -- A short-term memory loss may suggest the Alzheimer's disease, according to a new study made by Spanish researchers.The finding was published on Monday, in Archives of General Psychiatry, an American Medical Association journal.The researchers gathered data of 116 people with mild cognitive impairment (MCI) who developed Alzheimer's disease within two years, 204 patients with the condition who didn't develop Alzheimer's and 197 people with no cognitive problems.Mild cognitive impairment is usually marked by difficulties with short-term memory, such as losing your train of thought repeatedly or having trouble remembering what you did yesterday, according to the study.After assessing them by biomarker tests and cognitive measures, the researcher found the cognitive markers can forecast the variance."Remarkably, they accounted for nearly 50% of the predictive variance," said Dr. Gomar of Centro de Investigation Biomedica en Red de Salud Mental, Barcelona, who led the research.Mild cognitive impairment at the start of the study was a stronger predictor of Alzheimer's than most biomarkers, the researchers concluded.

SAN FRANCISCO, July 19 (Xinhua) -- Apple Inc. on Tuesday reported strong third fiscal quarter results that top analysts' expectations, citing strong iPhone and iPad sales.For its fiscal 2011 third quarter ended on June 25, Apple reported net income of 7.31 billion U.S. dollars or 7.79 dollars per share, compared with 3.25 billion dollars, or 3.51 dollars per share a year ago.Its revenue reached 28.57 billion dollars, compared with 15.7 billion dollars in the same period a year earlier. International sales accounted for 62 percent of the quarter's revenue.The average estimate is a profit of 5.84 dollars a share on revenue of 24.9 billion dollars.The Cupertino, Califronia-based company sold 20.34 million iPhones in the quarter, representing 142 percent unit growth over the year-ago quarter. It sold 9.25 million iPads in the third quarter, a 183 percent unit increase on a year-over-year basis.The only drawback is the sales of iPods, which had a 20 percent unit decline to 7.54 million from the year-ago quarter."We're thrilled to deliver our best quarter ever, with revenue up 82 percent and profits up 125 percent," Steve Jobs, Apple's chief executive officer, said in a statement."Right now, we're very focused and excited about bringing iOS 5 and iCloud to our users this Fall," added Job.It is the first time since 2008 that Apple's third-quarter earnings does not include the release of a new iPhone, which, slated for launch in September, is reportedly to be thinner and lighter with a faster chip and 8-megapixel camera.Apple has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. It had previously beaten the average earning projection for at least 29 straight quarters, according to data compiled by Bloomberg.For the fourth fiscal quarter of 2011, Apple's chief financial officer Peter Oppenheimer said the company expects revenue of 25 billion dollars and earnings per share of about 5.5 dollars. Apple has been known for its conservative projections of earnings.Apple has been operating without the daily attention of Jobs since the CEO took a medical leave this January. The Wall Street Journal reported Tuesday that some members of Apple's board have discussed CEO succession with executive recruiters and at least one head of a high-profile technology company.But the people familiar with the matter told the newspaper that it was more of an informal exploration of the company's options and don't appear to have been acting on behalf of the full board.Meanwhile, Apple has recently been busy with a number of legal battles over patent rights with HTC, Eastman Kodak and Samsung.Last week, the U.S. International Trade Commission made an initial ruling that HTC infringed two of Apple's phone patents in its smartphones powered by Google's Android operating system.If upheld, the ruling could let Apple force other Android phone makers to pay significant patent fees.On Tuesday, Google's executive chairman Eric Schmidt said at a conference in Tokyo that Apple's smartphone lawsuits are inspired by jealousy and a lack of innovation in iPhone, noting Google would support HTC's fight against Apple and was confident of a win.

BEIJING, Sept. 26 (Xinhuanet) -- One of the world's brightest minds aims to bring to the world a new, advanced three-dimensional image technology that will leave other such technology in the shadows."Our new technology will be better than that used in Avatar," says Professor Yau Shing-tung of Harvard University."The image will be more vivid than with technologies used in previous movies. The new technology is not only quicker but cheaper."Yau is one of the world's greatest mathematicians, having won the prestigious Fields Medal. He was once the dean of the department of mathematics at Harvard, and is now a professor there. He is also a visiting professor at Tsinghua University.Professor Yau and his team met professionals from Tsinghua University and Renmin University of China last week, and they discussed possible cooperation to apply the technology in making a demonstration movie using the new technology.Yau and a team started working on the new 3D technology, founded on geometrical principles, at Harvard 10 years ago.What marks it out is the extremely vivid pictures it produces.3D technology is used not only in making movies and in Internet games but in other areas , such as medicine. Movie audiences the world over were awestruck by the technology used in the movie Avatar."After I watched the movie, all I could say was 'Wow'," said Shen Yiren, an IT staff worker in Zhongguancun Science and Technology Park Zone. "3D technology has extended the boundaries of the human imagination."Yau says that six years ago the makers of Avatar had wanted him to cooperate with them but he turned them down."I was not sure that (Avatar) would be such a big success."Avatar's facial caption technology puts points on models' faces while the new technology uses geometric methods, saving time and money, Yau says.

WASHINGTON, Aug. 4 (Xinhua) -- U.S. scientists have found two gene mutations occurring in oligodendrogliomas, the second-most common form of brain cancer, according to a study to be published Friday in journal Science.For years scientists have been looking for the primary cancer genes involved in oligodendrogliomas evolvement. Scientists know the two chromosomes held the probable mutations, but the particular gene information remains unclear.Now scientists at Duke University Medical Center and Johns Hopkins University have discovered the most likely genetic mutations that researchers have been hunting for on chromosomes 1 and 19.The genes they identified, CIC or FUBP1, are tumor suppressor genes. The cancer-related pathways that involve these genes could become targets for future treatments, said Hai Yan, a Duke associate professor of pathology and co-corresponding author of the study.The researchers found CIC on chromosome 19 and FUBP1 on chromosome 1 based on an initial study of seven oligodendrogliomas. They found six mutations and two mutations, respectively, in the seven tumors. Further study of 27 more of these tumors showed that there were 12 and three mutations of CIC and FUBP1, respectively. The two genes were rarely mutated in other types of cancers, indicating that they are oligodendroglioma-specific genes.These genes were difficult to find until the technology improved, said Yan."The team used whole genome sequencing technology so that no genes would be excluded, and we found to our surprise that one gene, on chromosome 19, was mutated in six out of the seven initial tumor specimens we sequenced," Yan said. "A mutation frequency of 85 percent is very high."The finding of two additional new genes involved in oligodendrogliomas increases the chances for an effective combination drug therapy for the tumor, Yan said. He envisions a combination cocktail of drugs similar to the combination-drug treatments taken by HIV patients that would target different pathways involved in cancer, and assist both in reducing the chance of relapsing and increasing odds of success.